1,315 results on '"Chi, Dennis S."'
Search Results
402. Clear cell carcinoma of the cervix: A multi-institutional review in the post-DES era
403. In Brief
404. Colorectal Stents for Palliation of Large-Bowel Obstructions in Recurrent Gynecologic Cancer: An Updated Series
405. Low risk of complications associated with the fenestrated peritoneal catheter used for intraperitoneal chemotherapy in ovarian cancer
406. The impact of bulky upper abdominal disease cephalad to the greater omentum on surgical outcome for stage IIIC epithelial ovarian, fallopian tube, and primary peritoneal cancer
407. The effect of maximal surgical cytoreduction on sensitivity to platinum-taxane chemotherapy and subsequent survival in patients with advanced ovarian cancer
408. Nomogram for survival after primary surgery for bulky stage IIIC ovarian carcinoma
409. Prospective Study of the Correlation Between Postoperative Computed Tomography Scan and Primary Surgeon Assessment in Patients With Advanced Ovarian, Tubal, and Peritoneal Carcinoma Reported to Have Undergone Primary Surgical Cytoreduction to Residual Disease 1 cm or Less
410. Response and outcomes in elderly patients with stages IIIC–IV ovarian cancer receiving platinum–taxane chemotherapy
411. A prospective study of the accuracy of 18Fluorodeoxyglucose positron emission tomography (18FDG PET) in identifying sites of metastasis prior to pelvic exenteration
412. Platinum-based neoadjuvant chemotherapy for advanced ovarian cancer: A meta-analysis
413. Carcinosarcoma of the ovary treated with platinum and taxane: The memorial Sloan-Kettering Cancer Center experience
414. Intravaginal brachytherapy (IVRT) alone for patients with endometrial cancer meeting the PORTEC inclusion criteria
415. The outcomes of patients with positive margins after excision for intraepithelial Paget's disease of the vulva
416. The impact of video-assisted thoracic surgery (VATS) in patients with suspected advanced ovarian malignancies and pleural effusions
417. Clinicopathologic Features of Rhabdomyosarcoma of Gynecologic Origin in Adults
418. Distal partial gastrectomy and gastrojejunal anastomosis for recurrent ovarian cancer
419. Extended pelvic resection of iliacus muscle and femoral nerve for isolated recurrent uterine cancer
420. Superior pubic rami resection for isolated recurrent uterine cancer
421. Hand-assisted laparoscopic splenectomy for isolated ovarian cancer recurrence
422. Liver mobilization and diaphragm peritonectomy/resection
423. Retroperitoneal lymph node dissection
424. Delaying the primary surgical effort for advanced ovarian cancer: A systematic review of neoadjuvant chemotherapy and interval cytoreduction
425. Neoadjuvant chemotherapy for ovarian cancer: pro versus con
426. CA125 level as a predictor of progression-free survival and overall survival in ovarian cancer patients with surgically defined disease status prior to the initiation of intraperitoneal consolidation therapy
427. Role of aggressive surgical cytoreduction in advanced ovarian cancer.
428. Platinum-based neoadjuvant chemotherapy and interval surgical cytoreduction for advanced ovarian cancer: A meta-analysis
429. The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC–IV epithelial ovarian cancer
430. Fertility-sparing radical abdominal trachelectomy for cervical carcinoma: Technique and review of the literature
431. Incidence and management of pleural effusions after diaphragm peritonectomy or resection for advanced mullerian cancer
432. The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: A 12-year experience at Memorial Sloan-Kettering Cancer Center
433. Cystoscopic temporary ureteral catheterization during radical vaginal and abdominal trachelectomy
434. Paclitaxel and carboplatin in the adjuvant treatment of patients with high-risk stage III and IV endometrial cancer: A retrospective study
435. Retroperitoneal nodal metastasis in primary and recurrent granulosa cell tumors of the ovary
436. Identification of Prognostic Factors After Positive Second-Look Surgery in Epithelial Ovarian Carcinoma
437. En bloc resection of diaphragm with lung for recurrent ovarian cancer: A case report
438. Surgical resection of recurrent endometrial carcinoma
439. Phase I/II study of weekly paclitaxel plus carboplatin and gemcitabine as first-line treatment of advanced-stage ovarian cancer: Pathologic complete response and longitudinal assessment of impact on cognitive functioning
440. Laparoscopic and hand-assisted laparoscopic splenectomy for recurrent and persistent ovarian cancer
441. Laparoscopic findings during adnexal surgery in women with a history of nongynecologic malignancy
442. Apoptotic and cell cycle regulatory markers in uterine leiomyosarcoma
443. Mesorectal lymph node involvement and prognostic implications at total pelvic exenteration for gynecologic malignancies
444. Full-thickness diaphragmatic resection for stage IV ovarian carcinoma using the EndoGIA stapling device followed by diaphragmatic reconstruction using a Gore-tex® graft: A case report and review of the literature
445. Ovarian Cancer: Surgical Considerations.
446. Transfusion utilization during adnexal or peritoneal cancer surgery: Effects on symptomatic venous thromboembolism and survival
447. Fertility‐Sparing Options for Patients with Gynecologic Malignancies
448. Celiac disease presenting as a paraneoplastic syndrome in a patient with synchronous endometrial and ovarian cancers
449. Borderline endometrioid tumor arising in a paratubal cyst: a case report
450. Prolonged survival following salvage surgery for chemorefractory ovarian immature teratoma: a case report and review of the literature
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.